Evogene Ltd

Research Evogene Ltd (EVGN) on Bullrun: market cap USD 4.49M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEVGN
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.49M
• Financial periodQ1 2026

Valuation Snapshot

latest market cap is USD 4.49M.

About Evogene Ltd

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine.

Frequently asked questions

What is Evogene Ltd's market cap?

Evogene Ltd's market capitalization is USD 4.49M.

What does Evogene Ltd do?

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.